BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19028049)

  • 1. Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model.
    Dai J; Louedec L; Philippe M; Michel JB; Houard X
    J Vasc Surg; 2009 Mar; 49(3):719-27. PubMed ID: 19028049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution.
    Touat Z; Ollivier V; Dai J; Huisse MG; Bezeaud A; Sebbag U; Palombi T; Rossignol P; Meilhac O; Guillin MC; Michel JB
    Am J Pathol; 2006 Mar; 168(3):1022-30. PubMed ID: 16507915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of newly formed platelets in thrombus formation in rat after clopidogrel treatment: comparison to the reversible binding P2Y₁₂ antagonist ticagrelor.
    Kuijpers MJ; Megens RT; Nikookhesal E; Feijge MA; De Mey JG; oude Egbrink MG; van Giezen JJ; Heemskerk JW
    Thromb Haemost; 2011 Dec; 106(6):1179-88. PubMed ID: 22071958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel P2Y 12 antagonist AZD6140 rapidly and reversibly reduces platelet activation in diabetic rats.
    Flierl U; Schöpp C; Jaitner J; Bauersachs J; Schäfer A
    Thromb Res; 2010 Mar; 125(3):e93-9. PubMed ID: 19846210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAR216471, an alternative to the use of currently available P2Y₁₂ receptor inhibitors?
    Delesque-Touchard N; Pflieger AM; Bonnet-Lignon S; Millet L; Salel V; Boldron C; Lassalle G; Herbert JM; Savi P; Bono F
    Thromb Res; 2014 Sep; 134(3):693-703. PubMed ID: 25064036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apigenin Prevent Abdominal Aortic Aneurysms Formation by Inhibiting the NF-κB Signaling Pathway.
    Li D; Ma J; Wang L; Xin S
    J Cardiovasc Pharmacol; 2020 Mar; 75(3):229-239. PubMed ID: 31821190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ticagrelor and thienopyridine P2Y(12) binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hemostasis.
    van Giezen JJ; Berntsson P; Zachrisson H; Björkman JA
    Thromb Res; 2009 Nov; 124(5):565-71. PubMed ID: 19692114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel P2Y(12) adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models.
    Wang YX; Vincelette J; da Cunha V; Martin-McNulty B; Mallari C; Fitch RM; Alexander S; Islam I; Buckman BO; Yuan S; Post JM; Subramanyam B; Vergona R; Sullivan ME; Dole WP; Morser J; Bryant J
    Thromb Haemost; 2007 May; 97(5):847-55. PubMed ID: 17479197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc Prevents Abdominal Aortic Aneurysm Formation by Induction of A20-Mediated Suppression of NF-κB Pathway.
    Yan YW; Fan J; Bai SL; Hou WJ; Li X; Tong H
    PLoS One; 2016; 11(2):e0148536. PubMed ID: 26918963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraluminal abdominal aortic aneurysm thrombus is associated with disruption of wall integrity.
    Koole D; Zandvoort HJ; Schoneveld A; Vink A; Vos JA; van den Hoogen LL; de Vries JP; Pasterkamp G; Moll FL; van Herwaarden JA
    J Vasc Surg; 2013 Jan; 57(1):77-83. PubMed ID: 23127983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute arterial thrombosis in the absence of inflammation: the stress-related anti-inflammatory hormone ACTH participates in platelet-mediated thrombosis.
    Pozzi AO; Bernardo E; Coronado MT; Punchard MA; González P; Fantidis P
    Atherosclerosis; 2009 May; 204(1):79-84. PubMed ID: 18834983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.
    Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W
    Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of catalase in vascular smooth muscle cells prevents the formation of abdominal aortic aneurysms.
    Parastatidis I; Weiss D; Joseph G; Taylor WR
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2389-96. PubMed ID: 23950141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.
    Storey RF; Husted S; Harrington RA; Heptinstall S; Wilcox RG; Peters G; Wickens M; Emanuelsson H; Gurbel P; Grande P; Cannon CP
    J Am Coll Cardiol; 2007 Nov; 50(19):1852-6. PubMed ID: 17980251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
    Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
    Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticagrelor binds to human P2Y(12) independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation.
    VAN Giezen JJ; Nilsson L; Berntsson P; Wissing BM; Giordanetto F; Tomlinson W; Greasley PJ
    J Thromb Haemost; 2009 Sep; 7(9):1556-65. PubMed ID: 19552634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow mesenchymal stem cells stabilize already-formed aortic aneurysms more efficiently than vascular smooth muscle cells in a rat model.
    Schneider F; Saucy F; de Blic R; Dai J; Mohand F; Rouard H; Ricco JB; Becquemin JP; Gervais M; Allaire E
    Eur J Vasc Endovasc Surg; 2013 Jun; 45(6):666-72. PubMed ID: 23598054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elastogenic inductability of smooth muscle cells from a rat model of late stage abdominal aortic aneurysms.
    Gacchina CE; Deb P; Barth JL; Ramamurthi A
    Tissue Eng Part A; 2011 Jul; 17(13-14):1699-711. PubMed ID: 21341992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.